Immunomodulation in Endometriosis: Investigating the interrelationship between VISTA expression and Escherichia.Shigella-Associated metabolites
article
OA: closed
CC0
⤵ 1 in-corpus citation
AI-generated summary
This research investigated the relationship between VISTA expression and metabolites associated with *Escherichia* and *Shigella* in the context of endometriosis immunomodulation.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
AIMS: Endometriosis is characterized by an abnormal immune microenvironment. Despite the extensive use of immune therapies, the application of immune checkpoint inhibitors in endometriosis lacks confidence due to the instability of preclinical research data. This study aims to elucidate the regulation of the immune inhibitory checkpoint VISTA and its effects on T cells from the perspective of microbiota and metabolism.
MAIN METHODS: We divided endometriosis patients into high and low groups based on the expression levels of VISTA in lesion tissues. We collected peritoneal fluid samples from these two groups and performed 16 s RNA sequencing and metabolomics analysis to investigate microbial diversity and differential metabolites. Through combined analysis, we identified microbial-associated metabolites and validated their correlation with VISTA and CD8 + T cells using ELISA and immunofluorescence. In vitro experiments were conducted to confirm the regulatory relationship among these factors.
KEY FINDINGS: Our findings revealed a distinct correlation between VISTA expression and the microbial colony Escherichia.Shigella. Moreover, we identified the metabolites LTD4-d5 and 2-n-Propylthiazolidine-4-carboxylic acid as being associated with both Escherichia.Shigella and VISTA expression. In vitro experiments confirmed the inhibitory effects of these metabolites on VISTA expression, while they demonstrated a positive regulation of CD8 + T cell infiltration into endometriotic lesions.
SIGNIFICANCE: This study reveals the connection between microbial diversity, metabolites, and VISTA expression in the immune microenvironment of endometriosis, providing potential targets for therapeutic interventions.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (31)
- Immunohistochemistry expression of targeted therapies biomarkers in ovarian clear cell and endometrioid carcinomas (type I) and endometriosis via openalex
- Immunology of endometriosis via openalex
- Interleukin-12 inhibits development of ectopic endometriotic tissues in peritoneal cavity via activation of NK cells in a murine endometriosis model via openalex
- Macrophages alternatively activated by endometriosis-exosomes contribute to the development of lesions in mice via openalex
- Progesterone and Estrogen Signaling in the Endometrium: What Goes Wrong in Endometriosis? via openalex
- Reevaluating response and failure of medical treatment of endometriosis: a systematic review via openalex
- Rethinking mechanisms, diagnosis and management of endometriosis via openalex
- Role of cytokines in endometriosis via openalex
- The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres via openalex
- The Endobiota Study: Comparison of Vaginal, Cervical and Gut Microbiota Between Women with Stage 3/4 Endometriosis and Healthy Controls via openalex
- The endometrial immune environment of women with endometriosis via openalex
- Use of immunomodulators to treat endometriosis via openalex
- W3121724392 via openalex
- W3143313462 via openalex
- W3217384334 via openalex
- W4234160457 via openalex
- W4293572271 via openalex
- W4379780265 via openalex
- W1964380344 via openalex
- W4380682329 via openalex
- W2090152451 via openalex
- W2166932124 via openalex
- W2782205417 via openalex
- W2899296444 via openalex
- W2944310141 via openalex
- W2946242397 via openalex
- W2973158453 via openalex
- W2981635494 via openalex
- W2999762186 via openalex
- W3016339115 via openalex
- W3106005610 via openalex
Cited by (2)
Source provenance
- europepmc
- last seen: 2026-07-26T06:08:39.051465+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-07-26T06:06:20.640728+00:00
License: CC0
· commercial use OK